Skip to main content
. 2014 Nov 27;2014:793628. doi: 10.1155/2014/793628

Table 2.

Clinical and laboratory variables in 140 RA patients.

Variable Results
Clinical variables
 Systolic BP (mmHg) 126.6 (14.2) (range 90–160)
 Diastolic BP (mmHg) 79.5 (9.3) (range 50–100)
 BMI (kg/m2) 24.6 (3.8) (range 16–38.3)
 SCORE (%) 1.7 (2.6) (range 0–12)
 cIMT (mm) 0.79 (0.15) (range 0.43–1.2)
 Plaques present 40 (28.6%)
 QTc (ms) 335.5 (57.8) (range 186–487)
Laboratory variables
 CRP (mg/L) 19.5 (22.5) (range 0.1–116)
 ESR (mm/h) 35.9 (24.3) (range 5–102)
 Hemoglobin (g/dL) 12.5 (1.3) (range 9.2–16.4)
 Total protein (g/dL) 7.1 (0.6) (range 4.2–8.4)
 Albumin (g/dL) 4.2 (0.4) (range 2.3–5.0)
 Fibrinogen (g/L) 4.8 (1.3) (range 2.0–9.0)
 Total cholesterol (mg/dL) 200.1 (45.2) (range 98–365)
 HDL-C (mg/dL) 59.9 (15.8) (range 32–115)
 LDL-C (mg/dL) 117.4 (34.9) (range 38–245)
 Triglycerides (mg/dL) 117.3 (55.5) (range 24–300)
 Serum creatinine (mg/dL) 0.71 (0.23) (range 0.4–2.3)
 MDRD-eGFR (mL/min/1.73 m2) 106.0 (26.7) (range 22.9–156)
 Cystatin-C (mg/L) 0.77 (0.22) (range 0.42–1.66)
 Serum amyloid A (mg/L) 327.0 (263.4) (range 0–733.2)

Values are mean (SD) or numbers (%).

BP: blood pressure; BMI: body mass index; SCORE: systemic coronary risk evaluation; cIMT: carotid intima-media thickness; CRP: C-reactive protein; QTc: corrected QT interval; ESR: erythrocyte sedimentation rate; HDL-C: high-density lipoprotein cholesterol, LDL-C: low-density lipoprotein cholesterol; MDRD-eGFR: estimated glomerular filtration by modification of diet in renal disease.